Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.
<h4>Background</h4>A substantial number of patients presenting with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease (MVD) have severe left ventricular systolic dysfunction (LVSD) (left ventricular ejection fraction (LVEF) less than 35%). But data are lacking regar...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d80c512de032456a9b4e985d598d57ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d80c512de032456a9b4e985d598d57ad |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d80c512de032456a9b4e985d598d57ad2021-12-02T20:19:15ZMultivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.1932-620310.1371/journal.pone.0258525https://doaj.org/article/d80c512de032456a9b4e985d598d57ad2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0258525https://doaj.org/toc/1932-6203<h4>Background</h4>A substantial number of patients presenting with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease (MVD) have severe left ventricular systolic dysfunction (LVSD) (left ventricular ejection fraction (LVEF) less than 35%). But data are lacking regarding optimal percutaneous coronary intervention (PCI) strategy for these patients. The aim of this study was to compare the long-term outcomes of IRA (infarct-related artery)-only and multivessel PCI in patients with NSTEMI and MVD complicated by severe LVSD.<h4>Methods</h4>Among 13,104 patients enrolled in the PCI registry from November 2011 to December 2015, patients with NSTEMI and MVD with severe LVSD who underwent successful PCI were screened. The primary outcome was 3-year major adverse cardiovascular events (MACEs), defined as all-cause death, any myocardial infarction, stroke, and any revascularization.<h4>Results</h4>Overall, 228 patients were treated with IRA-only PCI (n = 104) or MV-PCI (n = 124). The MACE risk was significantly lower in the MV-PCI group than in the IRA-only PCI group (35.5% vs. 54.8%; hazard ratio [HR] 0.561; 95% confidence interval [CI] 0.378-0.832; p = 0.04). This result was mainly driven by a significantly lower risk of all-cause death (23.4% vs. 41.4%; hazard ratio [HR] 0.503; 95% confidence interval [CI] 0.314-0.806; p = 0.004). The results were consistent after multivariate regression, propensity-score matching, and inverse probability weighting to adjust for baseline differences.<h4>Conclusions</h4>Among patients with NSTEMI and MVD complicated with severe LVSD, multivessel PCI was associated with a significantly lower MACE risk. The findings may provide valuable information to physicians who are involved in decision-making for these patients.Myunhee LeeDae-Won KimMahn-Won ParkKyusup LeeSung-Ho HerKiyuk ChangWook Sung ChungMyung Ho JeongSeung-Woon RhaHyo-Soo KimHyeon Cheol GwonIn Whan SeongKyung Kuk HwangShung Chull ChaeKwon-Bae KimYoung Jo KimKwang Soo ChaSeok Kyu OhJei Keon ChaeJi-Hoon JungKAMIR-NIH registry investigatorsPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10, p e0258525 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Myunhee Lee Dae-Won Kim Mahn-Won Park Kyusup Lee Sung-Ho Her Kiyuk Chang Wook Sung Chung Myung Ho Jeong Seung-Woon Rha Hyo-Soo Kim Hyeon Cheol Gwon In Whan Seong Kyung Kuk Hwang Shung Chull Chae Kwon-Bae Kim Young Jo Kim Kwang Soo Cha Seok Kyu Oh Jei Keon Chae Ji-Hoon Jung KAMIR-NIH registry investigators Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction. |
description |
<h4>Background</h4>A substantial number of patients presenting with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease (MVD) have severe left ventricular systolic dysfunction (LVSD) (left ventricular ejection fraction (LVEF) less than 35%). But data are lacking regarding optimal percutaneous coronary intervention (PCI) strategy for these patients. The aim of this study was to compare the long-term outcomes of IRA (infarct-related artery)-only and multivessel PCI in patients with NSTEMI and MVD complicated by severe LVSD.<h4>Methods</h4>Among 13,104 patients enrolled in the PCI registry from November 2011 to December 2015, patients with NSTEMI and MVD with severe LVSD who underwent successful PCI were screened. The primary outcome was 3-year major adverse cardiovascular events (MACEs), defined as all-cause death, any myocardial infarction, stroke, and any revascularization.<h4>Results</h4>Overall, 228 patients were treated with IRA-only PCI (n = 104) or MV-PCI (n = 124). The MACE risk was significantly lower in the MV-PCI group than in the IRA-only PCI group (35.5% vs. 54.8%; hazard ratio [HR] 0.561; 95% confidence interval [CI] 0.378-0.832; p = 0.04). This result was mainly driven by a significantly lower risk of all-cause death (23.4% vs. 41.4%; hazard ratio [HR] 0.503; 95% confidence interval [CI] 0.314-0.806; p = 0.004). The results were consistent after multivariate regression, propensity-score matching, and inverse probability weighting to adjust for baseline differences.<h4>Conclusions</h4>Among patients with NSTEMI and MVD complicated with severe LVSD, multivessel PCI was associated with a significantly lower MACE risk. The findings may provide valuable information to physicians who are involved in decision-making for these patients. |
format |
article |
author |
Myunhee Lee Dae-Won Kim Mahn-Won Park Kyusup Lee Sung-Ho Her Kiyuk Chang Wook Sung Chung Myung Ho Jeong Seung-Woon Rha Hyo-Soo Kim Hyeon Cheol Gwon In Whan Seong Kyung Kuk Hwang Shung Chull Chae Kwon-Bae Kim Young Jo Kim Kwang Soo Cha Seok Kyu Oh Jei Keon Chae Ji-Hoon Jung KAMIR-NIH registry investigators |
author_facet |
Myunhee Lee Dae-Won Kim Mahn-Won Park Kyusup Lee Sung-Ho Her Kiyuk Chang Wook Sung Chung Myung Ho Jeong Seung-Woon Rha Hyo-Soo Kim Hyeon Cheol Gwon In Whan Seong Kyung Kuk Hwang Shung Chull Chae Kwon-Bae Kim Young Jo Kim Kwang Soo Cha Seok Kyu Oh Jei Keon Chae Ji-Hoon Jung KAMIR-NIH registry investigators |
author_sort |
Myunhee Lee |
title |
Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction. |
title_short |
Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction. |
title_full |
Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction. |
title_fullStr |
Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction. |
title_full_unstemmed |
Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction. |
title_sort |
multivessel versus ira-only pci in patients with nstemi and severe left ventricular systolic dysfunction. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/d80c512de032456a9b4e985d598d57ad |
work_keys_str_mv |
AT myunheelee multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT daewonkim multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT mahnwonpark multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT kyusuplee multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT sunghoher multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT kiyukchang multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT wooksungchung multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT myunghojeong multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT seungwoonrha multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT hyosookim multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT hyeoncheolgwon multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT inwhanseong multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT kyungkukhwang multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT shungchullchae multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT kwonbaekim multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT youngjokim multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT kwangsoocha multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT seokkyuoh multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT jeikeonchae multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT jihoonjung multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction AT kamirnihregistryinvestigators multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction |
_version_ |
1718374255119302656 |